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Brachial-ankle Pulse Wave Velocity As A Risk Stratiﬁcation Index For The Short-
term Prognosis Of Patients With Established Coronary Artery Disease
Sang Yeub Lee, sang min Kim, Jang-Whan Bae, Kyung-Kuk Hwang, Dong-Woon Kim,
Myeong-Chan Cho
Chungbuk Regional cardiovascular center, Cheongju-Si, Korea, Republic of
BACKGROUND AND OBJECTIVES Pulse wave velocity (PWV) is an index of arterial
stiffness and surrogate marker of subclinical cardiovascular disease. The clinical
application of baPWV in patients with established coronary artery disease (CAD) re-
mains unclear.
SUBJECTS (MATERIALS) AND METHODS We evaluated that brachial-ankle pulse wave
velocity (baPWV), a marker for arterial stiffness can be a risk stratiﬁcation index to
predict prognosis in patients with established CAD. We recruited the patients un-
dergoing emergent or elective CAG and PCI for stable angina or acute coronary
syndrome (non-ST-elevation and ST-elevation myocardial infarction, unstable
angina). The main outcome measures were cardiovascular (CV) death, deﬁnite/
probable stent thrombosis (ST), nonfatal myocardial infarction (MI), coronary
revascularization (PCI or CABG) and a composite end point of ischemic events.
PWV was determined using an automatic volume-plethysmographic device, form
PWV/ABI.
RESULTS In total, 925 patients were enrolled (Male 670, 72.4%) with median follow-
up of 524 days. All patients received optimal antiplatelet therapy and proper coronary
intervention. The higher baPWV was deﬁned as a median baPWV of 1730 cm s-1 or
more. The patients were diagnosed as ST elevation myocardial infarction (221, 23.0%),
non ST elevation myocardial infarction (221, 23.9%), unstable angina (294, 31.8%),
stable angina (189, 20.4%). The composite end points of the study at follow-up of 12
months were cardiovascular death, nonfatal myocardial infarction (MI), and coronary
revascularization. At a 12-month follow-up, we found 61 total ischemic events (higher
PWV 7.9% vs normal PWV 5.8% (p¼0.211)), 18 cardiovascular deaths (2.0% vs 1.9%
(p¼0.964)), 5 nonfatal MIs (0.8% vs 0.4% (p¼0.319)), 3 stent thrombosis (0.6% vs
0.3% (p¼0.313)) and 45 target-vessel revascularizations (5.9% vs 4.2% (p¼0.241)). In
survival analysis, there was no signiﬁcant difference between patient with higher
baPWV and normal velocity. Multivariate analysis revealed that a higher baPWV was
not signiﬁcantly associated with poorer short-term prognosis (hazard ratio, 0.793;
95% conﬁdence interval, 0.529-1.188) in established CAD patients.
CONCLUSIONS baPWV, a marker for arterial stiffness, is not a risk stratiﬁcation index
for short-term prognosis in patients with established CAD patients. Routine use of
PWV to predicting future cardiovascular events in patients with established CAD
seems to be unnecessary.
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The Impact of Monthly Multidisciplinary Formalized Data Feedback on Treatment
Times and Outcomes in ST Elevation Myocardial Infarction
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BACKGROUND We have previously reported signiﬁcant reductions in door-to-balloon
(D2B) and recognition-to-reperfusion (R2R) times by use of a fully automated wireless
network that transmits 12-lead ECG of patients with suspected ST elevation
myocardial infarction (STEMI) from emergency medical services (EMS) personnel in
the ﬁeld to smartphones worn by cardiologists (STAT-MI pathway). We now report
the effect of monthly multidisciplinary formalized data feedback on treatment times
in STEMI patients who presented through other non-automated STEMI pathways
(“walk-in” and un-networked EMS ambulances).
METHODS Prospective data on demographics, cardiac biomarkers, left ventricular
ejection fraction (LVEF) and all-cause mortality was collected in 147 who presented
through non STAT-MI pathway (“walk-in” and un-networked EMS) between June
2006 to May 2013. D2B, R2R, Total ischemic (TI), door-to-ﬁrst ECG (D2ECG) and door-
to-cardiac catheterization laboratory (D2LAB) times were discussed during monthly
multidisciplinary meetings at our institution using a formalized date feedback spread
sheets. Total study period was 84 months and data was analyzed by quarters.
RESULTS Between the 1st and 4th quarters median D2B time decreased signiﬁcantly
from 130 to 78.5 minutes (p<0.0001); the median D2ECG time decreased from 25 to 9.5
minutes (p¼0.02) and median D2LAB time decreased from 101 to 41.5 minutes
(p<0.0001). Post STEMI LVEF increased from 35  12 % to 53  14 % (p¼0.009) be-
tween 1st and 4th quarters. ECG Selvester score for estimating infarct size decreased
from 10.82  4.8 to 5.06  4.5 (p < 0.001).
The survival trend analysis showed improvement in survival rates from 0.70 to
0.90 (p¼0.04). Based on cox proportional hazards model the D2B time (HR1.006, p ¼
0.002), peak troponin (HR 1.004, p ¼ 0.04), hypertension (HR 5.75, p ¼ 0.02) and age
(HR 1.04, p ¼ 0.01) were strong independent predictors of mortality.
CONCLUSION Monthly formalized data feedback and detailed multidisciplinary
analysis of all STEMI presenters at our institution had resulted in signiﬁcant reduc-
tion in treatment times and improved outcomes. A Halo effect that extended from our
previously reported STAT-MI pathway.CRT-166
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BACKGROUND Drug eluting stent in-stent restenosis (DES-ISR) has a high recurrence
rate in spite of repeat balloon angioplasty or additional DES. Vascular brachytherapy
(VBT) is an option for refractory DES-ISR. However, it is unknown if there are gender-
based differences in presentation and outcome of recurrent DES-ISR treated with
VBT. This study aimed to report the gender-based differences in the baseline char-
acteristics and clinical outcomes of DES-ISR treated with VBT.
METHODS Patients undergoing VBT for DES-ISR were enrolled from an ongoing PCI
registry. Demographic, clinical and procedural data were collected. Outcomes of the
study were target lesion failure (TLR), cardiac death, myocardial infarction (MI), and
clinically driven target vessel revascularization (TVR) up to 3 years.
RESULTS A total of 100 men and 62 women underwent VBT for DES-ISR between
years 2003-2008. Mean age of the 2 groups was similar. Women more often pre-
sented with unstable symptoms (73% vs. 55%). There was no signiﬁcant difference in
the site and length of the lesion treated. Majority of males had previous bypass
grafting (63% vs. 38%); however, women with stented graft presented earlier than
men. (68 months vs. 114 months). Equal rates of procedural success were seen be-
tween the 2 groups; however, women had higher rate of vascular complications (8%
vs. 0%) than men. There was no signiﬁcant difference in the 6 months, 1, 2 and 3
years rates of TLR, TVR, MI and cardiac death (Figure) between men and women.
Both groups showed a time dependent attrition in the stent patency rates during the
3 year follow up.
CONCLUSIONS Although women had more unstable presentation and a higher rate of
vascular complications, procedural success and long terms outcomes were similar
between men and women undergoing VBT for refractory DES-ISR.CRT-167
Impact Of Hemoglobin A1c On Long-term Outcomes Of Drug-eluting Stents And
Bare Metal Stents Differently
Hideki Wada,1 Katsumi Miyauchi,2 Satoru Suwa,1 Hiroyuki Daida2
1Juntendo University, Shizuoka hospital, Izunokuni, Shizuoka, Japan; 2Juntendo
University, Tokyo, Japan
Previous studies showed admission levels of hemoglobin A1c (HbA1c) correlate
with long-term outcomes in patients with bare metal stents. It is uncertain that
HbA1c is associated with an increased risk of cardiovascular events in patients
undergoing DES.
METHODS AND RESULTS This study compared the impact of HbA1c on clinical out-
comes of BMS and DES in a single-center prospective registry. This was an observa-
tional study of 3,492 consecutive patients who underwent PCI between 2000 and
